Retinoic acid (RA) is used to treat leukemia and other cancers through its ability to promote cancer cell differentiation. Strategies to enhance the anticancer effects of RA could deepen …
J Congleton, R MacDonald, A Yen - Leukemia, 2012 - nature.com
Abstract All-trans-retinoic-acid (ATRA)-induced differentiation of human myeloid leukemia cells is characterized by persistent mitogen-activated protein kinase (MAPK) signaling …
RP Bunaciu, A Yen - Current pharmacology reports, 2015 - Springer
Acute promyelocytic leukemia (APL) is a treatment success story. From a highly deadly disease, it was turned into a highly curable disease by the introduction of differentiation …
6-Formylindolo (3, 2-b) carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was previously …
WM Geil, A Yen - The FEBS journal, 2014 - Wiley Online Library
Novel functions of signaling molecules have been revealed in studies of cancer stem cells. Retinoic acid (RA) is an embryonic morphogen and stem cell regulator that controls the …
A Rashid, X Duan, F Gao, M Yang, A Yen - Oncotarget, 2020 - ncbi.nlm.nih.gov
Although ATRA represents a successful differentiation therapy for APL, it is largely ineffective for non-APL AMLs. Hence combination therapies using an agent targeting ATRA …
A Rashid, X Duan, F Gao, M Yang, A Yen - Cellular Signalling, 2020 - Elsevier
All-trans retinoic acid (ATRA)-based differentiation therapy has been unsuccessful in treating t (15; 17) negative acute myeloid leukemia (AML) patients, motivating interest in …
CN Ibabao, RP Bunaciu, DMW Schaefer, A Yen - FEBS open bio, 2015 - Elsevier
In binary cell-fate decisions, driving one lineage and suppressing the other are conjoined. We have previously reported that aryl hydrocarbon receptor (AhR) promotes retinoic acid …
Increasing scientific evidence suggests that most diseases including cancer are driven by oxidative stress and inflammation, attributed to environmental factors such as diet. This book …